Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.
about
Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparumDrug-resistant malaria in Sudan: A review of evidence and scenarios for the futureHigh efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studiesTowards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasitesMolecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implicationsFrequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technologyIn vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, GabonAccess to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in BurundiMolecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern TanzaniaPlasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine.Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New GuineaA systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of Plasmodium vivax from Kolkata, India.Sulfadoxine-pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi.Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal.
P2860
Q24563685-EF5A1E57-F8D1-459B-81C7-A9D368E9DF1EQ26860010-FD875673-B42E-444B-A39C-087328804864Q28125935-662AF027-5CEC-4654-AD34-FD59A59491CCQ33979170-FA07E9D6-5D12-4CD8-B705-4FC0F77B3FE1Q33997904-044C55F9-F482-4323-A3AC-582AA89FF314Q34024767-4BF220D0-BC93-49E2-9270-EB4403301E94Q34134036-07D57F09-8758-4DDE-9816-FEA0DC2FA180Q34221842-CF9C38D7-744E-4DB3-9642-3A9FBF5C3C94Q34478362-F5161A57-596C-4F29-8F70-4A7F92739F5DQ34633242-8E1AEF24-7DB6-41D1-9607-8EEE77F49BBDQ34885646-F5F56E95-7C6D-4FC3-9C80-4266609033E3Q35069824-396F1A0E-DFBF-4A88-ADB0-720703797E29Q35784129-CE49BC32-AC1C-4063-98F4-66B062587E04Q36407073-65F4C8E4-699B-4093-A1A7-9E5AAAF5A5E7Q36649305-08C24717-1269-4E92-ACF5-BD0DD5A1A773Q37190605-00B347FA-3E29-4C49-9F10-C551CAA2D79AQ37390524-5B4A1DA2-77FC-4BEA-A4A8-FFF7A6C12087Q37544364-DC897561-885B-4027-AC36-FA5E421DE197Q39652433-992C4CC1-7210-4E6B-8F03-3BCEF4E79290Q41946531-81178C6A-BAF7-4B0B-AA01-70567BC6CF02
P2860
Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Molecular basis of in vivo res ...... falciparum malaria parasites.
@ast
Molecular basis of in vivo res ...... falciparum malaria parasites.
@en
type
label
Molecular basis of in vivo res ...... falciparum malaria parasites.
@ast
Molecular basis of in vivo res ...... falciparum malaria parasites.
@en
prefLabel
Molecular basis of in vivo res ...... falciparum malaria parasites.
@ast
Molecular basis of in vivo res ...... falciparum malaria parasites.
@en
P2860
P921
P356
P1476
Molecular basis of in vivo res ...... m falciparum malaria parasites
@en
P2093
P2860
P304
P356
10.1128/AAC.42.7.1811
P407
P577
1998-07-01T00:00:00Z